Development of Peptide-Based Inhibitors of Amylin Aggregation Employing Aromatic and Electrostatic Repulsion

Area of Science:

• Biochemistry
• Molecular Biology
• Endocrinology

Background:

• Human islet amyloid polypeptide (hIAPP) is co-secreted with insulin and implicated in type 2 diabetes pathogenesis.
• Misfolded hIAPP forms amyloid plaques in the pancreas, leading to beta-cell death and insulin deficiency.
• Soluble hIAPP oligomers, not insoluble fibrils, are the primary cytotoxic species.

Purpose of the Study:

• To identify peptide-based modulators that inhibit hIAPP self-assembly.
• To explore therapeutic strategies targeting hIAPP-mediated beta-cell death.
• To investigate the role of π-electronic effects and electrostatic charge repulsion in amyloid inhibition.

Main Methods:

• Utilized peptide-based modulators designed to interfere with hIAPP self-assembly.
• Employed strategies focusing on π-electronic effects to modulate aggregation.
• Incorporated electrostatic charge repulsion mechanisms to disrupt amyloid formation.

Main Results:

• Identified peptide modulators that prevent or alter hIAPP self-assembly.
• Demonstrated that tuning π-electron density can inhibit amyloid formation.
• Showcased the efficacy of charged elements in disrupting amyloid aggregation.

Conclusions:

• Peptide-based modulators targeting hIAPP self-assembly are promising therapeutic leads.
• Modulating π-electron density and utilizing charge repulsion are viable strategies for designing amyloid inhibitors.
• These findings contribute to the development of potential treatments for type 2 diabetes.